FRI-497-Shifting to sorafenib is beneficial for hepatocellular carcinoma patients with transarterial chemoembolization refractoriness: A real world experience.
Saved in:
| Title: | FRI-497-Shifting to sorafenib is beneficial for hepatocellular carcinoma patients with transarterial chemoembolization refractoriness: A real world experience. |
|---|---|
| Authors: | Po-Ting, Lin, Jeng, RachelWen-Juei, Hsieh, Yi-Chung, Teng, Wei, Hung, Chen-Fu, Huang, Chien-Hao, Lui, Kar-Wai, Chen, Yi-Cheng, Lin, Chen-Chun, Lin, Chun-Yen, Lin, Shi-Ming, Sheen, I-Shyan |
| Source: | Journal of Hepatology. Apr2019 Supplement, Vol. 70, pe618-e618. 1p. |
| Database: | Academic Search Ultimate |
| ISSN: | 01688278 |
|---|---|
| DOI: | 10.1016/S0618-8278(19)31232-0 |
